Clinical Trial Update: A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating corifollitropin alfa followed by low daily-dose hCG or recombinant FSH to induce monofollicular growth in women with WHO Group II anovu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulatory Infertility
• Infertility

Drugs mentioned

• Corifollitropin alfa (Corifollitropin alfa)
• Human chorionic gonadotropin (human chorionic gonadotropin)
• recombinant follicle-stimulating hormone (recombinant follicle-stimulating hormone)

Snippet

Sponsor: Organon and Co | Conditions: Ovulation Induction | Phase 2 | Status: TERMINATED | Results posted: 2014-06-09